Did anyone experienced bad complication after vaccination but no place to share?
Share your bad experiences, side effects or complications after completing your covid vaccination here:
https://t.co/PtXKxTOB0J
🚀 $CGC on 🔥 — 24%+ surge today!
💥 New quarterly growth in Canada
📈 Huge debt reduction — 49%
📊 This is the bottom? Or liftoff?
💡 Don’t sleep on this cannabis rocket! 🚀🚀
#CGC#CannabisStocks#Investing#StockMarket
Global cannabis market growth and potential U.S. rescheduling
Trading near its 52-week low, TLRY presents a speculative opportunity with significant upside potential.
Always conduct your own research before investing.
#TLRY#CannabisStocks#Investing#StockMarket
Why the buzz?
Upcoming Q4 FY2025 earnings on May 30
Launch of new high-demand cannabis products
Anticipation around U.S. cannabis rescheduling
Trading near its 52-week low, CGC presents a speculative opportunity with significant upside potential.
$CGC is catching fire today. Up 16% gain with strong volume!
Why the momentum?
US cannabis rescheduling gaining serious traction.
Class action clarity already priced in. Cost-cutting + margin improvement showing results
Trading under $1? High risk but higher reward potential
Federal rescheduling buzz could be a massive catalyst
Yes, revenue is down short-term, but margins are rising and strategic pivots are real.
With shares trading under $0.50, this is either a trap… or one of the biggest comeback plays of 2025.
$TLRY – Sleeping Giant?
Tilray is quietly building a multi-pronged empire:
THC beverages expanding into 10+ U.S. states
Alcohol & wellness acquisitions diversifying revenue
Reverse stock split vote June 10 to maintain Nasdaq compliance
What do you think? Moon or mirage?